Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

A simple high-throughput technology enables gain-of-function screening of human microRNAs.

Cheng WC, Kingsbury TJ, Wheelan SJ, Civin CI.

Biotechniques. 2013 Feb;54(2):77-86. doi: 10.2144/000113991.

2.

MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer.

Donnem T, Fenton CG, Lonvik K, Berg T, Eklo K, Andersen S, Stenvold H, Al-Shibli K, Al-Saad S, Bremnes RM, Busund LT.

PLoS One. 2012;7(1):e29671. doi: 10.1371/journal.pone.0029671. Epub 2012 Jan 25.

3.

Identification and characterization of microRNAs in vascular smooth muscle cells from patients with abdominal aortic aneurysms.

Cheuk BL, Cheng SW.

J Vasc Surg. 2014 Jan;59(1):202-9. doi: 10.1016/j.jvs.2013.02.244. Epub 2013 Jun 5.

4.

Unbiased Profile of MicroRNA Expression in Ascending Aortic Aneurysm Tissue Appoints Molecular Pathways Contributing to the Pathology.

Licholai S, Blaż M, Kapelak B, Sanak M.

Ann Thorac Surg. 2016 Oct;102(4):1245-52. doi: 10.1016/j.athoracsur.2016.03.061. Epub 2016 May 25.

PMID:
27234576
5.

Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma.

Wang J, Li Z, Ge Q, Wu W, Zhu Q, Luo J, Chen L.

J Thorac Cardiovasc Surg. 2015 May;149(5):1404-14.e4. doi: 10.1016/j.jtcvs.2015.02.012. Epub 2015 Feb 12.

6.

Identification of a new microRNA expression profile as a potential cancer screening tool.

Roa W, Brunet B, Guo L, Amanie J, Fairchild A, Gabos Z, Nijjar T, Scrimger R, Yee D, Xing J.

Clin Invest Med. 2010 Apr 1;33(2):E124.

PMID:
20370992
7.

MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer.

Chang KH, Mestdagh P, Vandesompele J, Kerin MJ, Miller N.

BMC Cancer. 2010 Apr 29;10:173. doi: 10.1186/1471-2407-10-173.

8.

Identification of known and novel germ cell cancer-specific (embryonic) miRs in serum by high-throughput profiling.

Rijlaarsdam MA, van Agthoven T, Gillis AJ, Patel S, Hayashibara K, Lee KY, Looijenga LH.

Andrology. 2015 Jan;3(1):85-91. doi: 10.1111/andr.298. Epub 2014 Nov 7.

9.

MicroRNA signatures in hereditary breast cancer.

Murria Estal R, Palanca Suela S, de Juan Jiménez I, Egoavil Rojas C, García-Casado Z, Juan Fita MJ, Sánchez Heras AB, Segura Huerta A, Chirivella González I, Sánchez-Izquierdo D, Llop García M, Barragán González E, Bolufer Gilabert P.

Breast Cancer Res Treat. 2013 Nov;142(1):19-30. doi: 10.1007/s10549-013-2723-7. Epub 2013 Oct 16.

PMID:
24129975
10.

MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas.

Butz H, Likó I, Czirják S, Igaz P, Korbonits M, Rácz K, Patócs A.

Pituitary. 2011 Jun;14(2):112-24. doi: 10.1007/s11102-010-0268-x.

PMID:
21063788
11.
12.

Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer.

Myatt SS, Wang J, Monteiro LJ, Christian M, Ho KK, Fusi L, Dina RE, Brosens JJ, Ghaem-Maghami S, Lam EW.

Cancer Res. 2010 Jan 1;70(1):367-77. doi: 10.1158/0008-5472.CAN-09-1891. Epub 2009 Dec 22.

13.

Optimization and analysis of a quantitative real-time PCR-based technique to determine microRNA expression in formalin-fixed paraffin-embedded samples.

Goswami RS, Waldron L, Machado J, Cervigne NK, Xu W, Reis PP, Bailey DJ, Jurisica I, Crump MR, Kamel-Reid S.

BMC Biotechnol. 2010 Jun 23;10:47. doi: 10.1186/1472-6750-10-47.

14.

miR Profiling Identifies Cyclin-Dependent Kinase 6 Downregulation as a Potential Mechanism of Acquired Cisplatin Resistance in Non-Small-Cell Lung Carcinoma.

Bar J, Gorn-Hondermann I, Moretto P, Perkins TJ, Niknejad N, Stewart DJ, Goss GD, Dimitroulakos J.

Clin Lung Cancer. 2015 Nov;16(6):e121-9. doi: 10.1016/j.cllc.2015.01.008. Epub 2015 Feb 3.

PMID:
25703099
15.

Altered retinal microRNA expression profile in a mouse model of retinitis pigmentosa.

Loscher CJ, Hokamp K, Kenna PF, Ivens AC, Humphries P, Palfi A, Farrar GJ.

Genome Biol. 2007;8(11):R248.

16.

Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC).

Jazdzewski K, Boguslawska J, Jendrzejewski J, Liyanarachchi S, Pachucki J, Wardyn KA, Nauman A, de la Chapelle A.

J Clin Endocrinol Metab. 2011 Mar;96(3):E546-53. doi: 10.1210/jc.2010-1594. Epub 2010 Dec 15.

17.

Cell-specific post-transcriptional regulation of γ-synuclein gene by micro-RNAs.

Surgucheva I, Gunewardena S, Rao HS, Surguchov A.

PLoS One. 2013 Sep 11;8(9):e73786. doi: 10.1371/journal.pone.0073786. eCollection 2013.

18.

MicroRNAs are differentially deregulated in mammary malignant phyllodes tumour.

Tsang JY, Ni YB, Ng EK, Shin VY, Mak KF, Go EM, Tawasil J, Chan SK, Ko CW, Kwong A, Tse GM.

Histopathology. 2015 Sep;67(3):294-305. doi: 10.1111/his.12648. Epub 2015 Mar 2.

PMID:
25585495
19.

MicroRNA alterations in head and neck squamous cell carcinoma.

Chang SS, Jiang WW, Smith I, Poeta LM, Begum S, Glazer C, Shan S, Westra W, Sidransky D, Califano JA.

Int J Cancer. 2008 Dec 15;123(12):2791-7. doi: 10.1002/ijc.23831.

20.

MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines.

Wagner A, Mayr C, Bach D, Illig R, Plaetzer K, Berr F, Pichler M, Neureiter D, Kiesslich T.

Int J Mol Sci. 2014 Nov 5;15(11):20134-57. doi: 10.3390/ijms151120134.

Supplemental Content

Support Center